Fluoxetine-induced alterations in human platelet serotonin transporter expression: Serotonin transporter polymorphism effects

Journal of Psychiatry and Neuroscience

Volumn 31, Issue 5, 2006, Pages 333-339

  Little, Karley Y ^a,c   Zhang, Lian ^a   Cook, Edwin ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c Ann Arbor Veterans Health System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; SEROTONIN; SEROTONIN TRANSPORTER;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EXPOSURE; ENZYME ACTIVITY; FEMALE; GENETIC POLYMORPHISM; HOMOZYGOSITY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MALE; NORMAL HUMAN; PROMOTER REGION; PROTEIN EXPRESSION; THROMBOCYTE;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; FEMALE; FLUOXETINE; GENOTYPE; HETEROZYGOTE DETECTION; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 33749333471     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Benmansour S, Cecchi M, Morilak DA, et al. Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level. J Neurosci 1999;19:10494-501.
2. Benmansour S, Owens WA, Cecchi M, et al. Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter. J Neurosci 2002;22:6766-72.
3. Blakely RD, Kamamoorthy S, Schroeter S, et al. Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins. Biol Psychiatry 1998;44:169-78.
4. Heinz A, Higley JD, Gorey JG, et al. In vivo association between alcohol intoxication, aggression, and serotonin transporter availability in nonhuman primates. Am J Psychiatry 1998;155:1023-8.
5. Little KY, McLaughlin DP, Zhang L, et al. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry 1998;155:207-13.
6. van Dyck CH, Malison RT, Staley JK, et al. Central serotonin transporter availability measured with [123I]beta-CIT SPECT in relation to serotonin transporter genotype. Am J Psychiatry 2004;161:525-31.
7. Lesch KP, Bengel D, Heils A, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527-31.
8. Stoltenberg SF, Twitchell G, Cook EH, et al. The serotonin transporter promoter polymorphism, peripheral indices of serotonin function and personality measures in families with alcoholism. Am J Med Genet 2002;114:230-4.
9. Greenberg BD, Tolliver TJ, Huang SJ, et al. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 1999;88:83-7.
10. Mann JJ, Huang YY, Underwood MD, et al. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 2000;57:729-38.
11. Willeit M, Stastny J, Pirker W, et al. No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism. Biol Psychiatry 2001;50:8-12.
12. Patkar AA, Berrettini WH, Mannelli P, et al. Relationship between serotonin transporter gene polymorphisms and platelet serotonin transporter sites among African-American cocaine-dependent individuals and healthy volunteers. Psychiatr Genet 2004;14:25-32.
13. Smeraldi E, Zanardi R, Benedetti F, et al. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 1998;3:508-11.
14. Pollock BG, Ferrell RE, Mulsant BH, et al. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression. Neuropsychopharmacology 2000;23:587-90.
15. Zanardi R, Benedetti F, DiBella D, et al. Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of serotonin transporter gene. J Clin Psychopharmacol 2000;20:105-7.
16. Yu YW, Tsai SJ, Chen TJ, et al. Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Mol Psychiatry 2002;7:1115-9.
17. Joyce PR, Mulder RT, Luty SE, et al. Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline. Int J Neuropsychopharmacol 2003;6:339-46.
18. Arias B, Catalan R, Gasto C, et al. 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study. J Clin Psychopharmacol 2003;23:563-7.
19. Rausch JL, Johnson ME, Fei YJ, et al. Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome. Biol Psychiatry 2002;51:723-32.
20. Kim DK, Lim SW, Lee S, et al. Serotonin transporter gene polymorphism and antidepressant response. Neuroreport 2000;11:215-9.
21. Yoshida K, Ito K, Sato K, et al. Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:383-6.
22. Arora RC, Meltzer HY. A modified assay method for determining serotonin uptake in human platelets. Clin Chim Acta 1981;112:225-33.
23. Little KY, Elmer LW, Zhong H, et al. Cocaine induction of dopamine transporter trafficking to the plasma membrane. Mol Pharmacol 2002;61:436-45.
24. Heils A, Teufel A, Petri S, et al. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996;66:2621-4.
25. Mundo E, Walker M, Cate T, et al. The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder preliminary findings. Arch Gen Psychiatry 2001;58:539-44.
26. Perlis RH, Mischoulon D, Smoller JW, et al. Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment. Biol Psychiatry 2003;54:879-83.
27. Rousseva A, Henry C, van den Bulke D, et al. Antidepressant-induced mania, rapid cycling and the serotonin transporter gene polymorphism. Pharmacogenomics J 2003;3:101-4.
28. Retz W, Retz-Junginger P, Supprian T, et al. Association of serotonin transporter promoter gene polymorphism with violence: relation with personality disorders, impulsivity, and childhood ADHD psychopathology. Behav Sci Law 2004;22:415-25.
29. Lin PY, Tsai G. Association between serotonin transporter gene promoter polymorphism and suicide: results of a meta-analysis. Biol Psychiatry 2004;55:1023-30.
30. Neuger J, El Khoury A, Kjellman BF, et al. Platelet serotonin function in untreated major depression. Psychiatry Res 1999;85:189-98.
31. Rosel P, Arranz B, Vallejo J, et al. Altered [3H]imipramine and 5-HT2 but not [3H]paroxetine binding sites in platelets from depressed patients. J Affect Dis 1999;52:225-33.
32. Meyer JH, Houle S, Sagrati S, et al. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. Arch Gen Psychiatry 2004;61:1271-9.
33. Little KY, McLaughlin DP, Ranc J, et al. Serotonin transporter binding sites and mRNA levels in depressed persons committting suicide. Biol Psychiatry 1997;41:1156-64.
34. Hoehe MR, Wendel B, Grunewald I, et al. Serotonin transporter (5-HTT) gene polymorphisms are not associated with susceptibility to mood disorders. Am J Med Genet 1998;81:1-3.
35. Posternak MA, Zimmerman M. Is there a delay in the antidepressant effect? A meta-analysis. J Clin Psychiatry 2005;66:148-58.
36. Kemp AH, Gray MA, Silberstein RB, et al. Augmentation of serotonin enhances pleasant and suppresses unpleasant cortical electrophysiological responses to visual emotional stimuli in humans. Neuroimage 2004;22:1084-96.
37. Harmer CJ, Bhagwagar Z, Perrett DI, et al. Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology 2003;28:148-52.
38. Carneiro AM, Blakely RD. Regulated alterations in platelet serotonin transporter localization and protein interactions, program no. 156.15, 2005. Washington, D.C.: Society for Neuroscience; 2005. Online.
39. Mulder EJ, Anderson GM, Kema IP, et al. Reactivity of serotonin in whole blood. Biol Psychiatry 2002;51:266-8.